AFP3d
U.S. FDA Approves AOP Health’s RapiblykTM (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting
Patients with first-degree atrioventricular block, sinus node dysfunction ... The risk is increased in patients with risk ...
Medscape6d
Switching Between Beta Blockers in Heart Failure Patients: Rationale and Practical Considerations
In addition to the physiological considerations and the evidence on survival (extending even to severe patients), the rationale for switching may be based on additional considerations that ...